This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa
The drug FERINJECT contains one active pharmaceutical ingredient (API):
|
1
Iron polymaltose
UNII 02414N8GQC - DEXTRIFERRON
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| FERINJECT Solution for injection/infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AB05 | Ferric oxide polymaltose complexes | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations |
| B03AC | Iron trivalent, parenteral preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10104T, 11702X |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501113010020402 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 1867-MEE-0316 |
| Country: EE | Ravimiamet | Identifier(s): 1236934, 1236945, 1387795, 1387807, 1548233, 1548244, 1671500, 1862535 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 69771 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 145795, 145817, 400244 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60960624 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 137526, 137529, 243929 |
| Country: HK | Department of Health Drug Office | Identifier(s): 64137, 64138 |
| Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-646532651 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6674 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3222404A1021 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1022620, 1022621, 1035297, 1035298, 1062875, 1062876, 1072065 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 15467112 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 115088, 89230, 89249 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 15189 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100220253 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W59531001, W59531002, W59531003, W59531004, W59531005, W59531006 |
| Country: SG | Health Sciences Authority | Identifier(s): 14035P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6653701H |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 45/8.3/0948 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
